Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype

K. Kramer Nielsen*, K. Brøsen, L. F. Gram, M. G.J. Hansen

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftLetterForskningpeer review

OriginalsprogEngelsk
TidsskriftEuropean Journal of Clinical Pharmacology
Vol/bind47
Udgave nummer2
Sider (fra-til)209-210
Antal sider2
ISSN0031-6970
DOI
StatusUdgivet - 1. sep. 1994

Citer dette

@article{b2933a444a734aa3a5b6f345a5db1a27,
title = "Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype",
keywords = "8-hydroxyclomipramine, co-regulation, Genetic polymorphism, glucuronidation, glucuronyl transferase, P450 isozymes",
author = "Nielsen, {K. Kramer} and K. Br{\o}sen and Gram, {L. F.} and Hansen, {M. G.J.}",
year = "1994",
month = "9",
day = "1",
doi = "10.1007/BF00194975",
language = "English",
volume = "47",
pages = "209--210",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Heinemann",
number = "2",

}

Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype. / Nielsen, K. Kramer; Brøsen, K.; Gram, L. F.; Hansen, M. G.J.

I: European Journal of Clinical Pharmacology, Bind 47, Nr. 2, 01.09.1994, s. 209-210.

Publikation: Bidrag til tidsskriftLetterForskningpeer review

TY - JOUR

T1 - Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype

AU - Nielsen, K. Kramer

AU - Brøsen, K.

AU - Gram, L. F.

AU - Hansen, M. G.J.

PY - 1994/9/1

Y1 - 1994/9/1

KW - 8-hydroxyclomipramine

KW - co-regulation

KW - Genetic polymorphism

KW - glucuronidation

KW - glucuronyl transferase

KW - P450 isozymes

UR - http://www.scopus.com/inward/record.url?scp=0028044040&partnerID=8YFLogxK

U2 - 10.1007/BF00194975

DO - 10.1007/BF00194975

M3 - Letter

VL - 47

SP - 209

EP - 210

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 2

ER -